Data as of Nov 7, 2026
65.182.186.232/30
No anonymizer space · no proxy exits in 30 daysConvergeone Holdings, Inc.
Registrations in this block
The registry's network records over this block, widest first, each under its parent.
| Range | Addresses | Netname | Holder | Type | Created | Abuse contact |
|---|---|---|---|---|---|---|
| 65.182.184.0/21 | 2,048 | NETSOURCE-NET-65-182-184-0 | Convergeone Holdings, Inc. (CH-1205) · US | Direct Allocation | Dec 17, 2003 | cvinje@ |
| └ 65.182.186.232/30 | 4 | NET-186-232 | unknown | — | — | — |
Network & registry
Announced by
Covering announcement 65.182.186.0/24
- Prefix
- 65.182.186.0/24
- Announced by
- AS22458 Convergeone Holdings, Inc.
- Type
- Hosting
- RPKI
- No RPKI
- Netname
- NETSOURCE-NET-65-182-184-0
- Registrant
- Convergeone Holdings, Inc.
- RIR
- ARIN
Origin network
AS22458
US
- Name
- Convergeone Holdings, Inc.
- Type
- Hosting
- Registered
- Aug 7, 2006
- Domain
- convergeone.com
- Industry
- Hosting and Cloud Provider
- Spamhaus ASN-DROP
- not listed
Routing timeline
Who has announced 65.182.186.0/24
65.182.186.0/24
Routing history
- Pattern
- Stable
- First seen
- Dec 2009
- Current origin since
- Aug 2016 · 10 yr
- Origin networks
- 2
- Last change of origin
- Aug 2016
Recorded history
History
- Handoffs
- 1
IRR
Route objects on 65.182.186.0/24
| Origin | Registry | Description | Maintainer | Modified |
|---|---|---|---|---|
| AS46887 not the origin | RADB | MAINT-AS27506 | Sep 3, 2025 |
Whois
Registration for this announcement
- Range
- 65.
182. 184. 0/ 21 - Netname
- NETSOURCE-NET-65-182-184-0
- Registrant
- Convergeone Holdings, Inc.
- Organization
- Convergeone Holdings, Inc. (CH-1205)
- Org address
- 10900 Nesbitt Ave S, Bloomington, MN, 55437
- Org country
- US
- Type
- Direct Allocation
- Handle
- NET-65-182-184-0-1
- Parent
- NET-65-0-0-0-0
- Created
- Dec 17, 2003
- RIR
- ARIN
- Country
- US
- Delegated
- Dec 17, 2003
- Status
- assigned
Report abuse
Abuse contact
- cvinje@
onec1. com - Name
- Chris Vinje
- Phone
- +1-651-393-3947
- Handle
- VINJE1-ARIN